©2024 Stanford Medicine
High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
Not Recruiting
Trial ID: NCT00186238
Purpose
To assess the role of autologous hematopoietic cell rescue in the treatment of multiple
myeloma.
Official Title
High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
Stanford Investigator(s)
Sally Arai
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Laura Johnston
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Robert Negrin
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Eligibility
Inclusion Criteria:- received cytoreduction prior to transplant
- adequate organ function Exclusion Criteria:- previous transplant
- smoldering MM or benign monoclonal gammopathy
Intervention(s):
procedure: high dose chemotherapy then autologous hematopoietic cell transplant
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
BMT Referrals
6507230822